PTPA and hereditary pheochromocytoma-paraganglioma: PP2A inhibition leads to phosophorylation and activation of PLK and allows for enhanced anticancer activity of chemotherapy directed against a GBM cell line [37] as well as a pheochromocytoma cell line [38].